Dianthus Therapeutics, Inc. (DNTH)
41.92
-0.21
(-0.50%)
USD |
NASDAQ |
Dec 15, 16:00
41.91
-0.01
(-0.02%)
Pre-Market: 20:00
Dianthus Therapeutics Market Cap: 1.797B for Dec. 15, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cytokinetics, Inc. | 7.600B |
| Lexicon Pharmaceuticals, Inc. | 446.98M |
| Day One Biopharmaceuticals, Inc. | 849.13M |
| CEL-SCI Corp. | 18.21M |
| AIM ImmunoTech, Inc. | 1.009M |
Market Cap Related Metrics
| PS Ratio | 491.79 |
| PEG Ratio | -0.3018 |
| Price to Book Value | 3.289 |
| Price | 41.92 |
| Earnings Yield | -8.33% |
| PEGY Ratio | -0.3018 |